Quadrant Capital Group’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,171
| Closed | -$93.6K | – | 2332 |
|
|
2025
Q1 | $93.6K | Sell |
3,171
-9
| -0.3% | -$266 | ﹤0.01% | 1539 |
|
|
2024
Q4 | $92.5K | Sell |
3,180
-59
| -2% | -$1.72K | 0.01% | 1094 |
|
|
2024
Q3 | $149K | Sell |
3,239
-69
| -2% | -$3.17K | 0.01% | 847 |
|
|
2024
Q2 | $135K | Hold |
3,308
| – | – | 0.01% | 840 |
|
|
2024
Q1 | $84.4K | Hold |
3,308
| – | – | 0.01% | 1102 |
|
|
2023
Q4 | $29.9K | Buy |
3,308
+2,714
| +457% | +$24.6K | ﹤0.01% | 1637 |
|
|
2023
Q3 | $3.79K | Buy |
+594
| New | +$3.79K | ﹤0.01% | 2241 |
|
|
2022
Q2 | – | Sell |
-29
| Closed | -$1K | – | 2702 |
|
|
2022
Q1 | $1K | Buy |
+29
| New | +$1K | ﹤0.01% | 2374 |
|